Daptomycin for Injection — Class II drug recall D-1023-2018
Terminated recall by PFIZER, reported 2018-08-08, distributed nationwide. Microbial Contamination of Sterile Products: Product associated with reports of adverse events indicative of i
| Recall number | D-1023-2018 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | PFIZER, Lake Forest, IL, United States |
| Recall initiated | 2018-06-28 |
| Classified | 2018-08-02 |
| Reported by FDA | 2018-08-08 |
| Terminated | 2022-08-25 |
| Distributed | Nationwide (US) |
| Quantity | 234,680 vials |
| Reason classes | microbial contamination, sterility |
| NDC | 00409-0106-01 |
| Lot numbers | 712453A, 771803A, 792103A, 800903A, 810853A, 841703A, 841753A, 850553A |
| Expiration dates | 2018-11-01, 2019-05-01, 2019-07-01, 2019-08-01, 2019-09-01, 2019-12-01, 2020-01-01 |
Product
Daptomycin for Injection, 500 mg per vial, packaged as 1 Single-dose vial per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-0106-01.
Reason for recall
Microbial Contamination of Sterile Products: Product associated with reports of adverse events indicative of infusion reactions related to microbiological contamination.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1023-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.